Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in the treatment of autism
IRCT201302201556N50Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in Autism Spectrum Disorder (ASD), sponsored by Tehran University of Medical Sciences. Started Mar 2013; status: completed.
02
Drugs
minocycline
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201302201556N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201302201556N50.